Barronsยท2025-11-10 21:15Mergers and Acquisitions - Pfizer agreed to acquire Metsera, a weight-loss drug start-up, for up to $86.25 per share, valuing the deal at over $10 billion. Pfizer will pay $65.60 in cash per share and additional contingent payments of up to $20.65 per share [3][4] - Metsera's board stated that Pfizer's revised bid represents the best transaction for shareholders in terms of value and certainty of closing, surpassing a previous bid from Novo Nordisk [3] Stock Movements - Metsera's stock dropped 15% to $70.75 following the acquisition announcement [3] - Nvidia's shares rose 3.1% after a 7% decline the previous week, attributed to optimism regarding the end of the government shutdown [5] - Tesla's stock gained 2.2% after a 3.7% decline on Friday, following shareholder approval of a significant pay package for CEO Elon Musk [6] Earnings Reports and Guidance - CoreWeave is expected to report quarterly earnings, with analysts predicting a loss of $0.40 per share on revenue of $1.26 billion [11] - Monday.com declined 15% after reporting third-quarter earnings that exceeded estimates but provided fourth-quarter revenue guidance below expectations [9] Other Notable Developments - Rumble's stock rose 17% after announcing an agreement to acquire Northern Data for up to $970 million [8] - TreeHouse Foods jumped 20% to $22.85 after agreeing to be taken private by Investindustrial in a $2.9 billion all-cash transaction [8] - Visa and Mastercard shares rose 0.2% amid reports of a potential settlement with merchants to lower fees and enhance their negotiating power [10]